Bandelow B, Boerner RJ, Kasper S et al. Generalisierte Angststörung: Diagnostik und Therapie. Dtsch Arztebl Int 2013; 110(17): 300-310.
Baric H, Dordevic V, Cerovecki I, Trkulja V. Complementary and Alternative Medicine Treatments for Generalized Anxiety Disorder: Systematic Review and Meta-analysis of Randomized Controlled Trials. Adv Ther 2018; 35(3): 261-288.
Batelaan NM, Bosman RC, Muntingh A et al. Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials. BMJ 2017; 358: j3927.
Burke J, Richards D, Timulak L. Helpful and Hindering Events in Internet-Delivered Cognitive Behavioural Treatment for Generalized Anxiety. Behav Cogn Psychother 2019; 47(3): 386-399.
Cramer H, Lauche R, Anheyer D et al. Yoga for anxiety: A systematic review and meta-analysis of randomized controlled trials. Depress Anxiety 2018; 35(9): 830-843.
Deutsche Gesellschaft für Psychosomatische Medizin und Ärztliche Psychotherapie (DGPM). S3-Leitlinie: Behandlung von Angststörungen. AWMF-Registernr.: 051-028. 2021.
Domhardt M, Geßlein H, von Rezori RE, Baumeister H. Internet- and mobile-based interventions for anxiety disorders: A meta-analytic review of intervention components. Depress Anxiety 2019; 36(3): 213-224.
Gale CK, Millichamp J. Generalised anxiety disorder. BMJ Clin Evid 2011: 1002.
Guaiana G, Barbui C, Cipriani A. Hydroxyzine for generalised anxiety disorder. Cochrane Database Syst Rev 2010; (12): CD006815.
Health Quality Ontario (HQO). Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment. Ont Health Technol Assess Ser 2019; 19(6): 1-199.
Health Quality Ontario (HQO). Psychotherapy for Major Depressive Disorder and Generalized Anxiety Disorder: A Health Technology Assessment. Ont Health Technol Assess Ser 2017; 17(15): 1-167.
Hieu TH, Dibas M, Surya Dila KA et al. Therapeutic efficacy and safety of chamomile for state anxiety, generalized anxiety disorder, insomnia, and sleep quality: A systematic review and meta-analysis of randomized trials and quasi-randomized trials. Phytother Res 2019; 33(6): 1604-1615.
Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Generalisierte Angststörung: Helfen Apps Betroffenen bei der Bewältigung ihrer Erkrankung? HTA-Bericht; Projekt-Nr. HT22-02. 2024.
Li X, Hou Y, Su Y et al. Efficacy and tolerability of paroxetine in adults with social anxiety disorder: A meta-analysis of randomized controlled trials. Medicine (Baltimore) 2020; 99(14): e19573.
Li X, Zhu L, Su Y, Fang S. Short-term efficacy and tolerability of venlafaxine extended release in adults with generalized anxiety disorder without depression: A meta-analysis. PLoS One 2017; 12(10): e0185865.
Li X, Zhu L, Zhou C et al. Efficacy and tolerability of short-term duloxetine treatment in adults with generalized anxiety disorder: A meta-analysis. PLoS One 2018; 13(3): e0194501.
National Institute for Health and Care Excellence (NICE). Generalised anxiety disorder and panic disorder in adults: management. (NICE Clinical guidelines; No. CG113). 2020.
Stefánsdóttir IH, Ivarsson T, Skarphedinsson G. Efficacy and safety of serotonin reuptake inhibitors (SSRI) and serotonin noradrenaline reuptake inhibitors (SNRI) for children and adolescents with anxiety disorders: a systematic review and meta-analysis. Nord J Psychiatry 2023; 77(2): 137-146.
Van Dis EA, van Veen SC, Hagenaars MA et al. Long-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Systematic Review and Meta-analysis. JAMA Psychiatry 2020; 77(3): 265-273.
Van Leeuwen E, van Driel ML, Horowitz MA et al. Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults. Cochrane Database Syst Rev 2021; (4): CD013495.
Wang SM, Woo YS, Kim NY et al. Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis. Clin Psychopharmacol Neurosci 2020; 18(3): 423-433.
IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.
Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.
Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.